Moreover, using the bone-marrow transplantation model of Ccr1-knockout mice, we have recently found that knockout of CCR1 expression in myeloid cells significantly suppressed tumor growth in primary and metastatic CRCs [80], which suggests that the use of CCR1 inhibitors can be a promising strategy to treat CRC. The gene discussed is CCR1; the disease is colorectal carcinoma.